|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 12,632.00 GBX | -0.69% |
|
-0.30% | -8.40% |
| 07-31 | EU Approves AstraZeneca and Daiichi Sankyo's Datroway for First-Line Triple-Negative Breast Cancer | MT |
| 07-31 | Astrazeneca, Daiichi Sankyo's Breast Cancer Therapy Receives EU approval | MT |
Main competitors
| P/E (N) | Price to Book (N) | PEG (N) | EV / Sales (N) | EV / EBITDA (N) | EV / EBIT (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
| 21.76x | 4.89x | 1.12x | 4.48x | 12.7x | 13.45x | 1.96% | 264B | ||
| 34.12x | 20.84x | 0.73x | 12.19x | 25.61x | 26.62x | 0.59% | 1,024B | ||
| 27.48x | 6.98x | -1.78x | 6.29x | 17.41x | 18.95x | 2.1% | 618B | ||
| 32.84x | 238.99x | 0.15x | 7.42x | 15.35x | 15.78x | 2.76% | 443B | ||
| 19.59x | 7.05x | 1.56x | 4.68x | 11.59x | 12.86x | 2.83% | 349B | ||
| 22.21x | 6.26x | -9.68x | 5.74x | 14.32x | 15.18x | 2.8% | 297B | ||
| 13.48x | 5.84x | -10.84x | 5.04x | 10.4x | 12.22x | 3.7% | 209B | ||
| 25.29x | 19.43x | 3.61x | 6.61x | 11.66x | 15.14x | 2.62% | 208B | ||
| -46.92x | 8.23x | 0.33x | 5.63x | 31.08x | 61.82x | 2.53% | 162B | ||
| 12.69x | 1.62x | 0.28x | 3.11x | 7.86x | 8.88x | 6.88% | 143B | ||
| 11.77x | 5.57x | 0.2x | 3.28x | 8.54x | 9.25x | 3.87% | 133B | ||
| 27.26x | 5.46x | 1.92x | 8.22x | 18.53x | 19.4x | -.--% | 121B | ||
| 12.71x | 7.3x | 1.66x | 2.79x | 8.35x | 9.22x | 3.6% | 104B | ||
| 12.02x | 1.2x | -3.78x | 2.09x | 6.72x | 7.57x | 5.69% | 103B | ||
| 22.46x | 5.08x | 1.32x | 7.55x | 14.32x | 15x | 1.98% | 71.57B | ||
| 44.26x | 1.18x | 21.12x | 2.73x | 9.18x | 27.88x | 3.71% | 55.24B | ||
| 20.77x | 1.68x | -0.13x | 1.73x | 8.23x | 13.81x | 0.47% | 54.3B | ||
| 38.84x | 5.18x | 2.16x | 8.87x | 29.61x | 32.41x | 0.49% | 52.81B | ||
| 18.88x | 1.89x | 4.67x | 3.41x | 12.76x | 14.31x | 2.21% | 43.08B | ||
| 46.97x | 4.7x | -1.22x | 3.18x | 11.7x | 13.23x | -.--% | 40.8B | ||
| Average | 20.92x | 17.97x | 0.67x | 5.25x | 14.29x | 18.15x | 2.54% | 224.76B | |
| Weighted average by Cap. | 23.44x | 32.79x | -0.49x | 6.99x | 16.84x | 19.36x | 2.25% |
- Stock Market
- Stocks
- AZN Stock
- Sector AstraZeneca PLC
- Sector valuations
Select your edition
All financial news and data tailored to specific country editions
















